Trial · NCT07116811
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
NCT07116811, Phase 3, Recruiting, Beijing Tiantan Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients. Trials, record NCT07116811. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07116811
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
- NCT number
- NCT07116811
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 364 participants, estimated
- Lead sponsor
- Beijing Tiantan Hospital
- Conditions
- Vestibular Schwannoma, Facial Nerve Paralysis
- Interventions
- Steroids therapy, Placebo
- First posted
- 2025-08-12
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Good facial nerve function (House-Brackmann grade I or II) at 90 days after surgery | at 90 (±7) days after surgery | Defined as House-Brackmann grade I or II. |
| Secondary | Good facial nerve function (House-Brackmann grade I or II) at 10 days after surgery | at 10 days after surgery | Defined as House-Brackmann grade I or II. |
| Secondary | Complete facial nerve function recovery (House-Brackmann grade I) at 90 days after surgery | at 90 (±7) days after surgery | Defined as House-Brackmann grade I |
| Secondary | Complete facial nerve function recovery (House-Brackmann grade I) at 10 days after surgery | at 10 days after surgery | Defined as House-Brackmann grade I |
| Secondary | Complete facial nerve function recovery (Sunnybrook scale 100 score) at 90 days after surgery | at 90 (±7) days after surgery | Sunnybrook Facial Grading System will be used. Score of 100 represents complete recovery. |
| Secondary | Complete facial nerve function recovery (Sunnybrook scale 100 score) at 10 days after surgery | at 10 days after surgery | Sunnybrook Facial Grading System will be used. Score of 100 represents complete recovery. |
| Secondary | Adverse events within 90 days | Within 90 (±7) days after surgery | |
| Secondary | Serious adverse events within 90 days | Within 90 (±7) days after surgery | |
| Secondary | Adverse events within 10 days | Within 10 days after surgery | |
| Secondary | Serious adverse events within 10 days | Within 10 days after surgery |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07116811
GET https://conductscience.org/api/trials/v1/NCT07116811/registered